FOXOs in the impaired heart: New therapeutic targets for cardiac diseases

  • Zhenlong Xin
  • , Zhiqiang Ma
  • , Shuai Jiang
  • , Dongjin Wang
  • , Chongxi Fan
  • , Shouyin Di
  • , Wei Hu
  • , Tian Li
  • , Junjun She
  • , Yang Yang

Research output: Contribution to journalReview articlepeer-review

73 Scopus citations

Abstract

Cardiac diseases have a high morbidity and mortality and affect the global population. Based on recent accumulating evidence, Forkhead box O (FOXOs) play important roles in cardiac diseases. Therefore, a summary of the current literature on the molecular mechanisms and roles of FOXOs in the heart will provide valuable information. In this review, we first briefly introduce the molecular features of FOXOs. Then, we discuss the regulation and cardiac actions of the FOXO pathways. Based on this background, we expand our discussion to the roles of FOXOs in several major cardiac diseases, such as ischemic cardiac diseases, diabetic cardiomyopathy and myocardial hypertrophy. Then, we describe some methodological problems associated with the FOXO gene-modified animal models. Finally, we discuss potential future directions. The information reviewed here may be significant for the design of future studies and may increase the potential of FOXOs as therapeutic targets.

Original languageEnglish
Pages (from-to)486-498
Number of pages13
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1863
Issue number2
DOIs
StatePublished - 1 Feb 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cardiac regeneration
  • Diabetic cardiomyopathy
  • Forkhead box O
  • Ischemic cardiac diseases
  • Myocardial hypertrophy

Fingerprint

Dive into the research topics of 'FOXOs in the impaired heart: New therapeutic targets for cardiac diseases'. Together they form a unique fingerprint.

Cite this